107 related articles for article (PubMed ID: 21524463)
21. Aberrant nuclear localization of beta-catenin without genetic alterations in beta-catenin or Axin genes in esophageal cancer.
Kudo J; Nishiwaki T; Haruki N; Ishiguro H; Shibata Y; Terashita Y; Sugiura H; Shinoda N; Kimura M; Kuwabara Y; Fujii Y
World J Surg Oncol; 2007 Feb; 5():21. PubMed ID: 17309796
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of astrocyte elevated gene-1 (AEG-1) is associated with esophageal squamous cell carcinoma (ESCC) progression and pathogenesis.
Yu C; Chen K; Zheng H; Guo X; Jia W; Li M; Zeng M; Li J; Song L
Carcinogenesis; 2009 May; 30(5):894-901. PubMed ID: 19304953
[TBL] [Abstract][Full Text] [Related]
23. Deregulated p21(WAF1) overexpression impacts survival of surgically resected esophageal squamous cell carcinoma patients.
Goan YG; Hsu HK; Chang HC; Chou YP; Chiang KH; Cheng JT
Ann Thorac Surg; 2005 Sep; 80(3):1007-16. PubMed ID: 16122475
[TBL] [Abstract][Full Text] [Related]
24. Caspase expression in oral squamous cell carcinoma.
Coutinho-Camillo CM; Lourenço SV; Nishimoto IN; Kowalski LP; Soares FA
Head Neck; 2011 Aug; 33(8):1191-8. PubMed ID: 21755562
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of nm23-H1 expression in esophageal squamous cell carcinoma.
Wang LS; Chow KC; Lien YC; Kuo KT; Li WY
Eur J Cardiothorac Surg; 2004 Aug; 26(2):419-24. PubMed ID: 15296908
[TBL] [Abstract][Full Text] [Related]
26. The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma.
Ando T; Ishiguro H; Kimura M; Mitsui A; Mori Y; Sugito N; Tomoda K; Mori R; Harada K; Katada T; Ogawa R; Fujii Y; Kuwabara Y
Oncol Rep; 2007 Sep; 18(3):601-9. PubMed ID: 17671707
[TBL] [Abstract][Full Text] [Related]
27. Prognostic factors and family history for survival of esophageal squamous cell carcinoma patients after surgery.
Yuequan J; Shifeng C; Bing Z
Ann Thorac Surg; 2010 Sep; 90(3):908-13. PubMed ID: 20732516
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of MAGE-A and NY-ESO-1 expression in pharyngeal cancer.
Pastorcic-Grgic M; Sarcevic B; Dosen D; Juretic A; Spagnoli GC; Grgic M
Head Neck; 2010 Sep; 32(9):1178-84. PubMed ID: 20029985
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of Tiam1 predicts poor prognosis in patients with esophageal squamous cell carcinoma.
Liu H; Shi G; Liu X; Wu H; Fan Q; Wang X
Oncol Rep; 2011 Mar; 25(3):841-8. PubMed ID: 21186404
[TBL] [Abstract][Full Text] [Related]
30. Tumor length as a prognostic factor in esophageal malignancy: univariate and multivariate survival analyses.
Griffiths EA; Brummell Z; Gorthi G; Pritchard SA; Welch IM
J Surg Oncol; 2006 Mar; 93(4):258-67. PubMed ID: 16496364
[TBL] [Abstract][Full Text] [Related]
31. Expression and prognostic significance of EFNB2 and EphB4 genes in patients with oesophageal squamous cell carcinoma.
Tachibana M; Tonomoto Y; Hyakudomi R; Hyakudomi M; Hattori S; Ueda S; Kinugasa S; Yoshimura H
Dig Liver Dis; 2007 Aug; 39(8):725-32. PubMed ID: 17611172
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in human esophageal carcinoma: implications for prognosis.
Porte H; Triboulet JP; Kotelevets L; Carrat F; Prévot S; Nordlinger B; DiGioia Y; Wurtz A; Comoglio P; Gespach C; Chastre E
Clin Cancer Res; 1998 Jun; 4(6):1375-82. PubMed ID: 9626453
[TBL] [Abstract][Full Text] [Related]
33. p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx.
Vielba R; Bilbao J; Ispizua A; Zabalza I; Alfaro J; Rezola R; Moreno E; Elorriaga J; Alonso I; Baroja A; de la Hoz C
Laryngoscope; 2003 Jan; 113(1):167-72. PubMed ID: 12514403
[TBL] [Abstract][Full Text] [Related]
34. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
[TBL] [Abstract][Full Text] [Related]
35. MiRNAs and their association with locoregional staging and survival following surgery for esophageal carcinoma.
Hummel R; Hussey DJ; Michael MZ; Haier J; Bruewer M; Senninger N; Watson DI
Ann Surg Oncol; 2011 Jan; 18(1):253-60. PubMed ID: 20628822
[TBL] [Abstract][Full Text] [Related]
36. Have surgical outcomes of pathologic T4 esophageal squamous cell carcinoma really improved? Analysis of 268 cases during 45 years of experience.
Shimada H; Shiratori T; Okazumi S; Matsubara H; Nabeya Y; Shuto K; Akutsu Y; Hayashi H; Isono K; Ochiai T
J Am Coll Surg; 2008 Jan; 206(1):48-56. PubMed ID: 18155568
[TBL] [Abstract][Full Text] [Related]
37. Correlation between gp96 expression and the surgical outcome in patients with esophageal squamous cell carcinoma.
Akutsu Y; Matsubara H; Kano M; Usui A; Yoneyama Y; Ikeda N; Komatsu A; Yusup G
Ann Surg Oncol; 2011 Mar; 18(3):832-7. PubMed ID: 20839070
[TBL] [Abstract][Full Text] [Related]
38. An inducible short-hairpin RNA vector against osteopontin reduces metastatic potential of human esophageal squamous cell carcinoma in vitro and in vivo.
Ito T; Hashimoto Y; Tanaka E; Kan T; Tsunoda S; Sato F; Higashiyama M; Okumura T; Shimada Y
Clin Cancer Res; 2006 Feb; 12(4):1308-16. PubMed ID: 16489088
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma.
Hashimoto Y; Ito T; Inoue H; Okumura T; Tanaka E; Tsunoda S; Higashiyama M; Watanabe G; Imamura M; Shimada Y
Clin Cancer Res; 2005 Apr; 11(7):2597-605. PubMed ID: 15814639
[TBL] [Abstract][Full Text] [Related]
40. Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus.
Koide N; Nishio A; Sato T; Sugiyama A; Miyagawa S
Am J Gastroenterol; 2004 Sep; 99(9):1667-74. PubMed ID: 15330899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]